Biosynthesis and characterization of exopolysaccharide from Lactiplantibacillus plantarum RSM51 with antioxidant and antidiabetic potential
The growing demand for innovative biotherapeutics requires comprehensive characterization of novel probiotic strains with desirable health-promoting attributes and established safety profiles. This study provides genomic and physicochemical analyses of the exopolysaccharide (EPS) producing strain Lactiplantibacillus plantarum RSM51, evaluating its probiotic potential and biopolymer characteristics. Whole-genome sequencing (WGS) of isolate Lb. plantarum RSM51 was performed, and the assembled genome comprises 3.37 Mbp with a GC content of 44.35%. To investigate the genetic basis of EPS production, the genome was systematically screened for gene clusters associated with EPS biosynthesis. The in silico analysis predicted a complement of genes encoding glycosyltransferases, polymerization enzymes, and transport machinery potentially involved in heteropolysaccharide assembly and export. Furthermore, the crude EPS yield of Lb. plantarum RSM51 was approximately 410 mg/L. Physicochemical characterization of the crude biopolymer, designated EPS-RSM51, by Fourier-transform infrared (FTIR) spectroscopy indicated a polysaccharide structure. Scanning electron microscopy (SEM) of the EPS exhibited an irregular, porous, and amorphous morphology. Elemental analysis via Energy-dispersive X-ray (EDX) spectroscopy showed the polymer was primarily composed of carbon and oxygen, with minor amounts of nitrogen and phosphorus. Moreover, crude EPS-RSM51 exhibited moderate antioxidant activity, with an IC 50 of 5.84 mg/mL in the DPPH assay, 1.70 mg/mL in the FRAP assay, and 3.64 mg/mL in the NO assay. Additionally, crude EPS-RSM51 revealed potent inhibition of α-amylase (IC 50 = 3.28 mg/mL) and α-glucosidase (IC 50 = 3.12 mg/mL). Therefore, this study provides insight into the predicted EPS biosynthetic capacity and the experimentally determined physicochemical properties of EPS-RSM51, thereby supporting the evidence-based integration of crude EPS-RSM51 into functional food and nutraceutical applications.
Authors
- Nancy M. El Halfawy (ORCID: https://orcid.org/0000-0002-5687-0158)
- Aliaa A. Masoud (ORCID: https://orcid.org/0000-0002-9182-0121)
- Shaimaa G. Abdelmonaem (ORCID: https://orcid.org/0009-0006-6064-6374)
Institutions
- Alexandria University (EG)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-75630-w
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Development Fund
- Alexandria University